Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan
Breast Cancer: Targets and Therapy · 2026-06 · Volume 18 · 1-14
DOI: 10.2147/bctt.s595563 ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Cancer: Targets and Therapy, 2026-06. Verfasst von Yang-Chuan Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.
- Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.
- Department of Oncology, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.
- Department of Medical Research, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.
- Graduate Institute of Public Health, College of Public Health, National Defense Medical University, Taipei, Taiwan.
- Taiwanese Injury Prevention and Safety Promotion Association (TIPSPA), Taipei, Taiwan.
ORCID-Profile: Yang-Chuan Chen, Po-Huang Chen, Chi-Hsiang Chung
Zitieren
APA
Chen, Y. C., Cheng, M. C., Chen, P. H., Chung, C. H., Chien, W. C., Dai, M. S., Chen, J. H., & Huang, T. C. (2026). Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan. Breast Cancer: Targets and Therapy, Volume 18, 1-14. https://doi.org/10.2147/bctt.s595563
Vancouver
Chen YC, Cheng MC, Chen PH, Chung CH, Chien WC, Dai MS, et al. Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan. Breast Cancer: Targets and Therapy. 2026;Volume 18:1-14. doi:10.2147/bctt.s595563
BibTeX
@article{Chen2026,
author = {Chen, Yang-Chuan and Cheng, Min-Chi and Chen, Po-Huang and Chung, Chi-Hsiang and Chien, Wu-Chien and Dai, Ming-Shen and Chen, Jia-Hong and Huang, Tzu-Chuan},
title = {Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan},
journal = {Breast Cancer: Targets and Therapy},
year = {2026},
volume = {Volume 18},
pages = {1--14},
doi = {10.2147/bctt.s595563}
}
EUVIMED